Position: Vice President, Market Access & Strategy, CommercialPhiladelphia, PA (Hybrid)About the PositionReporting to the Chief Commercial Officer, the Vice President (VP), Market Access & Strategy is responsible for establishing the strategic foundation for pricing, reimbursement, policy, and evidence generation to support successful commercialization of Cabaletta Bio's CAR-T therapies. This role ensures optimal access through strong value demonstration, reimbursement infrastructure, and proactive policy strategy.
Key ResponsibilitiesPricing Strategy - Lead development of U.S. pricing strategy aligned with product value, market dynamics, and access goals.
Medicare & Medicaid Strategy - Lead Medicare billing, coding development, and submission processes.
- Oversee Medicaid strategy and execution across states.
Provider Reimbursement - Develop and implement provider reimbursement strategies, including coding and payment pathways.
HEOR & Value Evidence - Lead Health Economics and Outcomes Research (HEOR) strategy.
- Partner with Medical Affairs to generate evidence supporting payer value propositions.
Market Research & Insights - Oversee payer and hospital market research to inform pricing, access strategy, and evidence needs.
Government Affairs & Policy - Monitor and shape healthcare policy impacting reimbursement and access.
- Engage with external stakeholders and industry groups.
Payer Tools & Communications - Lead development of payer-focused materials and promotional tools to communicate value effectively.
Advisory Boards & Stakeholder Alignment - Co-lead payer and hospital advisory boards to refine strategy and gather insights.
Pipeline & Business Development Support - Partner with New Product Planning (NPP) on future indications and business development opportunities.
Qualifications - Advanced degree preferred (MBA, PhD, PharmD, MD, or equivalent).
- 15+ years of experience in pricing, reimbursement, market access strategy, or HEOR.
- Deep expertise in Medicare/Medicaid policy, coding, and reimbursement frameworks.
- Experience in cell/gene therapy or complex specialty products strongly preferred.
- Strong analytical, strategic, and cross-functional leadership skills.
Our name - Cabaletta - is derived from the operatic term that represents a rapid, repetitive, and technically challenging section of an operatic aria, where the second act is designed to showcase the skills of the lead singer. Analogously, Cabaletta Bio strives to achieve rapid and repetitive product development, building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.
For more information, please visit https://www.cabalettabio.com/join-our-crew
Our most important asset is our people, and we offer competitive benefits, PTO, and stock option plans.
#LI-HYBRID 
